Ensol Biosciences (XKRX:140610) Total Inventories : ₩23 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ensol Biosciences Total Inventories?

Ensol Biosciences's total inventories for the quarter that ended in Dec. 2024 was ₩23 Mil. Ensol Biosciences's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Dec. 2024 was ₩12 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Ensol Biosciences's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was ₩-2,567.54.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Ensol Biosciences's Days Inventory for the six months ended in Dec. 2024 was 176.93.

Inventory Turnover measures how fast the company turns over its inventory within a year. Ensol Biosciences's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ensol Biosciences's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.01.

Ensol Biosciences Total Inventories Historical Data

The historical data trend for Ensol Biosciences's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensol Biosciences Total Inventories Chart

Ensol Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

Get a 7-Day Free Trial

142.50

309.91

255.27

23.22

Ensol Biosciences Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Total Inventories	Get a 7-Day Free Trial						142.50	309.91	255.27	-	23.22

Ensol Biosciences Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Ensol Biosciences (XKRX:140610) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Ensol Biosciences's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1696.912	+	0.75 * 26.093	+	0.5 * 23.219	-	29768.224
-	0	-	0)	/	10.921
=	-2,567.54

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ensol Biosciences's Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	11.6095	/	11.975	*	365 / 2
	=	176.93

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ensol Biosciences's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	11.975	/	11.6095
	=	1.03

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ensol Biosciences's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	11.6095	/	1434.621
	=	0.01

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Ensol Biosciences Total Inventories Related Terms

Thank you for viewing the detailed overview of Ensol Biosciences's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Ensol Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ensol Biosciences Inc (XKRX:140610) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

51, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34036

Website

http://www.ensolbio.co.kr

Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.

Ensol Biosciences Headlines

No Headlines